Efficacy of Seprafilm for prevention of postoperative adhesions after liver surgery: clinical study

Efficacy of Seprafilm for prevention of postoperative adhesions after liver surgery: clinical study - Prevention of adhesions by Seprafilm after liver surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003414

Enrollment

200

Registered

2010-03-31

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma and metastatic cancer of the liver

Interventions

application of Seprafilm after hepatectomy for the treatment of hepatocellular carcinoma or metastatic liver tumors

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases of hepatectomy scheduled for the treatment of hepatocellular carcinoma or metastatic liver tumors in our department.

Exclusion criteria

Exclusion criteria: If the patient has peritonitis or infectious complications, If the patient has the history of severe allergy, If dissection of lymph node or other is requred, or If the patients do not agree, the patients will be excluded from this study.

Design outcomes

Primary

Measure	Time frame
adhesion scores, time and amount of the blood loss needed for dissecting the adhesions in reoperation of the liver in future	—

Countries

Japan

Contacts

Public ContactNorihiro Kokudo

Graduate School of Medicine, University of University of Tokyo Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery

kihase-tky@umin.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026